1Lewington S,Clarke R,Qizilbash N.Age_specific relevance of usual blood pressure to vascular mortality:a meta_analysis of individual data for one million adults in 61 prospective studies[J].Lancet,2002,360(9349):1903-1913.
5Rembek M,Goch A,Goch J.The clinical course of acute ST_elevation myocardial infarction in patients with hypertension[J].Kardiol Pol,2010,68(2):157-163.
6Figueras J,Cortadellas J,Calvo F,et al.Relevance of delayed hospital admission on develpment of cardiac rupture during acute myocardial infarction:study in 225 patients with free wall,septal or papillary muscle rupture[J].J Am Coll Cardiol,1998,32(1):135-139.
7Richards AM,Nicholls MG,Troughton RW,et al.Antecedent hypertension and heart failure after myocardial infarction[J].J Am Coll Cardiol,2002,39(7):1182-1188.
8Thune JJ,Signorovitch J,Kober L,et al.Effect of antecedent hypertension and follow_up blood pressure on outcomes after high_risk myocardial infarction[J].Hypertension,2008,51(1):48-54.
9Fresco C,Auanzini F,Bosi S,et al.Prognostic value of a history of hypertension in 11,483 patients with acute myocardial infarction treated with thrombolysis.GISSI_2 Investigators.Gruppo Italiano per lo Studio della,Sopravvivena nell'Infarto Miocardico[J].J Hypertens,1996,14(6):743-750.
10Frazier CG,Shah SH,Armstrong PW,et al.Prevalence and management of hypertension in acute coronary syndrome patients varies by sex:observations from the Sibrafiban versus aspirin to Yield Maximum Protection from ischemic Heart events postacute c Oro Nary s Yndromes(SYMPHONY)randomized clinical trials[J].Am Heart J,2005,150(6):1260-1267.
4Antman EM, Anbe DT, Armstrong PW, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction-executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1999 guidelines for the management of patients with acute myocardial infarction). J Am Coil Cardiol, 2004,44: 671-719.
5Smith SC Jr, Allen J, Blair SN, et al. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute. Circulation, 2006, 113 : 2363-2372.
6Hasdai D, Behar S, Wallentin L, et al. A prospective survey of the characteristics, treatments and outcomes of patients with acute coronary syndromes in Europe and the mediterranean basin. The survey of acute coronary syndromes. Eur Heart J, 2002, 23:1190- 1201.
7Carruthers KF, Dabbous OH, Flather MD, et al. Contemporary management of acute coronary syndromes : does the practice match the evidence? The global registry of acute coronary events (GRACE). Heart, 2005, 91: 290-298.
8Peterson ED, Roe MT, Mulgund J, et al. Association between hospital process performance and outcomes among patients with acute coronary syndromes. JAMA, 2006, 295: 1912-1920.
9饶克勤.中国卫生统计年鉴2005.北京:协和医科大学出版社,2006:3-15.
10Newby LK, LaPointe NM, Chen AY, et al. Long-term adherence to evidence-based secondary prevention therapies in coronary artery disease. Circulation, 2006, 113: 203-212.
